Isolates of Clostridium perfringens recovered from Costa Rican patients with antibiotic-associated diarrhoea are mostly enterotoxin-negative and susceptible to first-choice antimicrobials

Journal of Medical Microbiology

Volumn 57, Issue 3, 2008, Pages 343-347

  Camacho, Natassia ^a   Espinoza, Carlos ^a   Rodríguez, César ^a   Rodríguez, Evelyn ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ENTEROTOXIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN G; RIFAMPICIN;

AGAR DILUTION; AGGLUTINATION TEST; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; COSTA RICA; CPE GENE; DIARRHEA; FECES ANALYSIS; GENOTYPE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; COSTA RICA; DIARRHEA; ENTEROTOXINS; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 40549113308     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47505-0     Document Type: Article

References (36)

1. Alexander, C. J., Citron, D. M., Brazier, J. S. & Goldstein, E. J. C. (1995). Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol 33, 3209-3215.
2. Allen, S. D., Emery, C. L. & Siders, J. A. (1999). Clostridium. In Manual of Clinical Microbiology, 7th edn, pp. 654-671. Edited by P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover & R. H. Yolken. Washington, DC: American Society for Microbiology.
3. Asha, N. J. & Wilcox, M. H. (2002). Laboratory diagnosis of Clostridium perfringens antibiotic-associated diarrhea. J Med Microbiol 51, 891-894.
4. Asha, N. J., Tompkins, D. & Wilcox, M. H. (2006). Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 44, 2785-2791.
5. Beaugerie, L. & Petit, J.-C. (2004). Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 18, 337-352.
6. Billington, S. J., Wieckowski, E. U., Sarker, M. R., Bueschel, D., Songer, J. G. & McClane, B. A. (1998). Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin gene sequences. Infect Immun 66, 4531-4536.
7. Borriello, S. P., Larson, H. E., Welch, A. R., Barclay, F., Stringer, M. F. & Bartholomew, B. A. (1984). Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhea. Lancet 11, 305-307.
8. Citron, D. M., Merriam, C. V., Tyrrell, K. L., Warren, Y. A., Fernandez, H. & Goldstein, E. J. C. (2003). In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob Agents Chemother 47, 2334-2338.
9. Citron, D. M., Kwok, Y. Y. & Appleman, M. D. (2005). In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci. Anaerobe 11, 93-95.
10. Czeczulin, J. R., Hanna, P. C. & McClane, B. A. (1993). Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect Immun 61, 3429-3439.
11. Czeczulin, J. R., Collie, R. E. & McClane, B. A. (1996). Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C. perfringens. Infect Immun 64, 3301-3309.
12. Fach, P. & Popoff, M. (1997). Detection of enterotoxigenic Clostridium perfringens in food and fecal samples with a duplex PCR and the slide latex agglutination test. Appl Environ Microbiol 63, 4232-4236.
13. Finegold, S. M., John, S. S., Vu, A. W., Li, C. M., Molitoris, D., Song, Y., Liu, C. & Wexter, H. M. (2004). In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora. Anaerobe 10, 205-211.
14. Forward, L. J., Tompkins, D. S. & Brett, M. M. (2003). Detection of Clostridium difficile cytotoxin and Clostridium perfringens enterotoxin in cases of diarrhoea in the community. J Med Microbiol 52, 753-757.
15. García-Alvarado, J. S., Labbé, R. G. & Rodríguez, M. A. (1992). Sporulation and enterotoxin production by Clostridium perfringens type A at 37°C and 43°C. Appl Environ Microbiol 58, 1411-1414.
16. Goldstein, E. J., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrel, K. L. & Fernandez, H. T. (2003). In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 Gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother 47, 337-341.
17. Hecht, D. W., Malamy, M. H. & Tally, F. P. (1989). Mechanisms of resistance and resistance transfer in anaerobic bacteria. In Anaerobic Infections in Humans, pp. 755-769. Edited by S. M. Finegold & W. L. George. New York: Academic Press.
18. Holdeman, L. V., Cato, E. P. & Moore, W. E. C. (1977). Anaerobe Laboratory Manual, 4th edn. Blacksburg, VA: Virginia Polytechnic Institute and State University, Anaerobe Laboratory.
19. Labbé, R. (2001). Clostridium perfringens. In Compendium of Methods for the Microbiological Examination of Foods, 4th edn, pp. 325-330. Edited by F. Pouch Downes & K. Ito. Washington, DC: American Public Health Association.
20. Land, K. M. & Johnson, P. J. (1999). Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resist Updat 2, 289-294.
21. Liu, W. T., Marsh, T. L., Cheng, H. & Forney, L. J. (1997). Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol 63, 4516-4522.
22. McClane, B. A. & Chakrabarti, G. (2004). New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin. Anaerobe 10, 107-114.
23. Modi, N. & Wilcox, M. (2001). Evidence for antibiotic induced Clostridium perfringens diarrhoea. J Clin Pathol 54, 748-751.
24. Morera, J., Rodriguez, E. & Gamboa, M. M. (1999). Determinación de Clostridium perfringens en embutidos de carne de cerdo del área metropolitana de Costa Rica. Arch Latinoam Nutr 49, 279-282.
25. Murphy, T. F., Barza, M. & Park, J. T. (1981). Penicillin-binding proteins in Clostridium perfringens. Antimicrob Agents Chemother 20, 809-813.
26. NCCLS (2004). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved Standard, 6th edn. Wayne, PA: National Committee on Clinical Laboratory Standards.
27. Petit, L., Gilbert, M. & Popoff, M. R. (1999). Clostridium perfringens: toxinotype and genotype. Trends Microbiol 7, 104-110.
28. Pituch, H., van den Braak, N., van Belkum, A., van Leeuwen, W., Obuch-Woszczatynski, P., Luczak, M., Verbrugh, H., Meisel-Mikolajczyk, F. & Martirosian, G. (2002). Characterization of Clostridium perfringens strains isolated from Polish patients with suspected antibiotic-associated diarrhea. Med Sci Monit 8, 85-88.
29. Poutanen, S. M. & Simor, A. E. (2004). Clostridium difficile-associated diarrhea in adults. Can Med Assoc J 171, 51-58.
30. Sindar, P., Britz, M. L. & Wilkinson, R. G. (1982). Isolation and properties of metronidazole-resistant mutants of Clostridium perfringens. J Med Microbiol 15, 503-509.
31. Smedley, J. G., III, Fisher, D. J., Sayeed, S., Chakrabarti, G. & McClane, B. A. (2004). The enteric toxins of Clostridium perfringens. Rev Physiol Biochem Pharmacol 152, 183-204.
32. Sparks, S. G., Carman, R. J., Sarker, M. R. & McClane, B. A. (2001). Genotyping of enterotoxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America. J Clin Microbiol 39, 883-888.
33. Vela, M., Heredia, N. L., Feng, P. & Garcia Alvarado, S. (1999). DNA probe analysis for the carriage of enterotoxigenic Clostridium perfringens in feces of a Mexican subpopulation. Diagn Microbiol Infect Dis 35, 101-104.
34. Wexler, H. M., Molitoris, D. & Finegold, S. M. (2001). In vitro activity of gatifloxacin against 238 strains of anaerobic bacteria. Anaerobe 7, 285-289.
35. Wiström, J., Norrby, S. R., Myhre, E. B., Eriksson, S., Granström, G., Lagergren, L., Englund, G., Nord, C. E. & Svenungsson, B. (2001). Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47, 43-50.
36. Yoo, H. S., Lee, S. U. & Park, K. Y. (1997). Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR. J Clin Microbiol 35, 228-232.